1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study. (10th December 2020) Authors: Diab, Adi; Tykodi, Scott; Daniels, Gregory; Maio, Michele; Curti, Brendan; Lewis, Karl; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander; Cho, Daniel; Guan, Shanhong; Puente, Erika; Hoch, Ute; Currie, Sue; Nguyen, Tuan; Lin, Wei; Tagliaferri, Mary; Zalevsky, Jonathan; Sznol, Mario Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study. (9th November 2020) Authors: Diab, Adi; Tykodi, Scott; Daniels, Gregory; Maio, Michele; Curti, Brendan; Lewis, Karl; Jang, Sekwon; Kalinka, Ewa; Puzanov, Igor; Spira, Alexander; Cho, Daniel; Guan, Shanhong; Puente, Erika; Hoch, Ute; Currie, Sue; Nguyen, Tuan; Lin, Wei; Tagliaferri, Mary; Zalevsky, Jonathan; Sznol, Mario Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 797 Significant anti-tumor activity of HBI-8000, a class I histone deacetylase inhibitor (HDACi) in combination with nivolumab (NIVO) in anti-PD1 therapy-naïve advanced melanoma (TN-Mel). (10th December 2020) Authors: Khushalani, Nikhil; Brohl, Andrew; Markowitz, Joseph; Bazhenova, Lyudmila; Daniels, Gregory; Yeckes-Rodin, Heather; Fu, Siqing; McCormick, Lori; Kurman, Michael; Gillings, Mireille; Lee, Gloria; Eroglu, Zeynep Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data. (10th December 2020) Authors: Fernandez-Penas, Pablo; Carlino, Matteo; Tsai, Katy; Atkinson, Victoria; Shaheen, Monaster; Thomas, Sajeve; Mihalcioiu, Catalin; Hagen, Tom Van; Roberts-Thomson, Rachel; Haydon, Andrew; Mant, Andrew; Butler, Marcus; Daniels, Gregory; Buchbinder, Elizabeth; Hyngstrom, John; Moller, Mecker; Puzanov... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A multi-center study of high dose Aldesleukin (Proleukin® (HD IL-2) + Vemurafenib Zelboraf® ) therapy in patients with BRAFV600 mutation positive metastatic melanoma (proclivity 01). (6th November 2014) Authors: Clark, Joseph; Flaherty, Lawrence; Ernstoff, Marc; Koon, Henry; Milhem, Mohammed; Militello, Gerald; Agarwala, Sanjiv; Curti, Brendan; Cranmer, Lee; Lao, Christopher D; Logan, Theodore F; Lutzky, Jose; Rudrapatna, Venkatesh; Daniels, Gregory; Taback, Bret; Aung, Sandra; Lowder, James; Lawson, David Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma. Issue 1 (December 2016) Authors: Buchbinder, Elizabeth; Gunturi, Anasuya; Perritt, Jessica; Dutcher, Janice; Aung, Sandra; Kaufman, Howard; Ernstoff, Marc; Miletello, Girald; Curti, Brendan; Daniels, Gregory; Patel, Sapna; Kirkwood, John; Hallmeyer, Sigrun; Clark, Joseph; Gonzalez, Rene; Richart, John; Lutzky, Joe; Morse, Michae... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2). Issue 2 (December 2015) Authors: Clark, Joseph; Morse, Michael; Wong, Michael; McDermott, David; Kaufman, Howard; Daniels, Gregory; Perritt, Jessica; Hua, Hong; Aung, Sandra Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma. Issue 2 (December 2015) Authors: Chandar, Ashwin; Silk, Ann; Clark, Joseph; Daniels, Gregory; McDermott, David; Morse, Michael; Wong, Michael; Stein, Mark; Mehnert, Janice; Danish, Shabbar; Aung, Sandra; Kaufman, Howard Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗